Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-11-013518
Filing Date
2011-03-08
Accepted
2011-03-08 16:44:29
Documents
9
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 v213743_10k.htm 10-K 2988783
2 GRAPHIC chart.jpg GRAPHIC 86531
3 v213743_ex10-49.htm EX-10.49 27431
4 v213743_ex10-50.htm EX-10.50 22374
5 v213743_ex23-1.htm EX-23.1 3173
6 v213743_ex31-1.htm EX-31.1 16374
7 v213743_ex31-2.htm EX-31.2 16181
8 v213743_ex32-1.htm EX-32.1 6466
9 v213743_ex32-2.htm EX-32.2 6100
  Complete submission text file 0001144204-11-013518.txt   3207208
Mailing Address 4520 EAST-WEST HIGHWAY, SUITE 300 BETHESDA MD 20814
Business Address 4520 EAST-WEST HIGHWAY, SUITE 300 BETHESDA MD 20814 3019613400
Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

EIN.: 133929237 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33609 | Film No.: 11672480
SIC: 2834 Pharmaceutical Preparations